2022
Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III Substudy
Patel K, Lansky A, Kereiakes D, Windecker S, Cristea E, Pietras C, Dressler O, Issever M, Curtis M, Bertolet B, Zidar J, Smits P, Díaz V, McLaurin B, Brogno D, Janssens L, Vrolix M, Gómez-Blázquez I, Sahul Z, Kabour A, Salido L, Cleman M, Saito S, Leon M, Baumbach A, Investigators I. Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III Substudy. Journal Of The Society For Cardiovascular Angiography & Interventions 2022, 1: 100004. DOI: 10.1016/j.jscai.2021.100004.Peer-Reviewed Original ResearchDrug-eluting stentsTarget lesion failureDP-EESComplex lesionsLesion failureAdverse eventsLesion complexityMajor adverse cardiac eventsSingle-blind clinical trialEnd pointAdverse cardiac eventsChronic coronary syndromePrimary end pointSecondary end pointsTarget lesion revascularizationTarget vessel failureComplex coronary lesionsPercutaneous coronary interventionEverolimus-eluting stentsDrug eluting stentsHigh rateLesion revascularizationCoronary syndromeCardiac eventsCoronary intervention
1993
Clinical and Angiographic Determinants of Initial Percutaneous Transluminal Coronary Angioplasty Success
Ilia R, Kolanski D, Setaro J, Brennan J, Cabin H, Cleman M, Remetz M. Clinical and Angiographic Determinants of Initial Percutaneous Transluminal Coronary Angioplasty Success. Angiology 1993, 44: 677-682. PMID: 8357092, DOI: 10.1177/000331979304400901.Peer-Reviewed Original ResearchConceptsCoronary angioplastyPercutaneous transluminal coronary angioplastyTransluminal coronary angioplastyAcute myocardial infarctionSuccess rateDegree of stenosisLong-term pretreatmentAngiographic determinantsAngioplasty successPostinfarction anginaAngiographic characteristicsSuccessful angioplastyClinical featuresMyocardial infarctionAnatomic determinantsPrimary successAngioplastyPatientsSuccessful procedureAspirinBeneficial effectsLesionsHigh rateAdditional findingsAngina